Orange Book product · Brand (NDA)
FANAPT
ILOPERIDONE
At a glance
May 06, 2009
Approved
Brand (NDA)
Application
Not listed
TE code
10
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 06, 2009
17 yr 4 mo ago
Today
Exclusivity ends · I-939
New indication exclusivity (3 years)
Apr 02, 2027
in 10 mo
Patent 8586610 expires
Listed method-of-use patent (U-1625) expiration.
Nov 02, 2027
in 1 yr 5 mo
Patent 9157121 expires
Listed method-of-use patent (U-1674) expiration.
Apr 05, 2030
in 3 yr 10 mo
Patent 8652776 expires
Listed method-of-use patent (U-1685) expiration.
Aug 31, 2030
in 4 yr 3 mo
Patent 12606869 expires
Listed method-of-use patent (U-4504) expiration.
Sep 22, 2030
in 4 yr 4 mo
Patent 12606869 expires
Listed method-of-use patent (U-4505) expiration.
Sep 22, 2030
in 4 yr 4 mo
Patent 8999638 expires
Listed method-of-use patent (U-1674) expiration.
Oct 28, 2030
in 4 yr 5 mo
Patent 9074255 expires
Listed method-of-use patent (U-1674) expiration.
Dec 17, 2030
in 4 yr 7 mo
Patent 9072742 expires
Listed method-of-use patent (U-1674) expiration.
Jan 16, 2031
in 4 yr 8 mo
Patent 9074256 expires
Listed method-of-use patent (U-1674) expiration.
Feb 10, 2031
in 4 yr 9 mo
Patent 9074254 expires
Listed method-of-use patent (U-1674) expiration.
Dec 28, 2031
in 5 yr 7 mo
Pharmaceutical detail
Active ingredient
ILOPERIDONE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
NDA 022192
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
Marketing exclusivity (1)
- I-939New indication exclusivity (3 years)
Apr 02, 2027
in 10 mo
Listed patents (10)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8586610 | Nov 02, 2027 | in 1 yr 5 mo | U-1625 |
| 9157121 | Apr 05, 2030 | in 3 yr 10 mo | U-1674 |
| 8652776 | Aug 31, 2030 | in 4 yr 3 mo | U-1685 |
| 12606869 | Sep 22, 2030 | in 4 yr 4 mo | U-4504 |
| 12606869 | Sep 22, 2030 | in 4 yr 4 mo | U-4505 |
| 8999638 | Oct 28, 2030 | in 4 yr 5 mo | U-1674 |
| 9074255 | Dec 17, 2030 | in 4 yr 7 mo | U-1674 |
| 9072742 | Jan 16, 2031 | in 4 yr 8 mo | U-1674 |
| 9074256 | Feb 10, 2031 | in 4 yr 9 mo | U-1674 |
| 9074254 | Dec 28, 2031 | in 5 yr 7 mo | U-1674 |
